2,993 results found

Health Canada has released a revised version of the draft guidance document "Information and Submission Requirements for Subsequent Entry Biologics".

On June 20, 2023, Canada's Patented Medicines Prices Review Board (PMPRB) published a proposed interim guidance for the prices of new patented medicines...

On December 9, the Government of Canada published proposed amendments to the Food and Drug Regulations and the Medical Devices Regulations (Regulations).

On October 5, the Québec government introduced Bill 148, An Act to regulate generic medication procurement by owner pharmacists and to amend various legislative provisions.

The federal government's plan to revitalize the access to information framework has commenced. The first phase, Bill C-58: An Act to amend the Access to Information Act

The impact of increased Indigenous engagement in infrastructure projects comes in many forms, says Valerie Helbronner, and that impact will only increase.

Two themes are shaping the internal investigation landscape in 2026: intensifying scrutiny of procurement activity and the increasingly cross‑border nature of workplace issues.

An essential government activity that historically has rarely made front page news, government procurement has suddenly become a central focus for citizens around the world.

Canada's Minister of Innovation, Science and Industry (the Minister) recently announced significant legislative reforms to the Investment Canada Act (the Act) to bolster national security reviews.

The Government of Canada plans to invest $85.3 million in the IP Strategy over the next five years.

Canada Comes Back On Board for Business Method Patents

The environment is on the minds of consumers these days. And in response, a multitude of products and services claiming to be green or eco-friendly are stacking supermarket aisles.

The long-awaited amendments to Canada’s Bankruptcy and Insolvency Act (BIA) and Companies’ Creditors Arrangements Act (CCAA) came into force on September 18, 2009.

In our December 30, 2004 bulletin (no. IPB2004-5), we described the small entity fee debacle highlighted by the decision in Barton No-Till Disk Inc. v. Dutch Industries, and we reported that the federal government had introduced amendments to the Patent Act (in Bill C-29) to allow patent holders to retroactively correct the situation.

Nearly five years after receiving royal assent, amendments to the Trademarks Act will come into force on June 17, 2019.

The Patented Medicine Prices Review Board (PMPRB) has announced a delay in the coming-into-force of the amended Patent Medicines Regulations (the Regulations) to January 1, 2021.

When the Act respecting the class action was adopted in 1978,1 both plaintiff and defendant could appeal, as of right, from a judgment on an application for authorization to institute a class action.